Adverse events in different administration routes of amiodarone: a pharmacovigilance study based on the FDA adverse event reporting system

Adverse events in different administration routes of amiodarone: a pharmacovigilance study based on the FDA adverse event reporting system

BackgroundArrhythmias are prevalent cardiac disorders with significant impacts on patient quality of life and mortality. Amiodarone, a class III antiarrhythmic agent, is widely used to manage both atrial and ventricular arrhythmias due to its efficacy in prolonging the cardiac action potential and i...

Full description

Bibliographic Details
Main Authors: Jingrong Yang, Mengfan You, Jingxin Wang, Rongfei Sun, Lili Han, Xiaonan Liu, Kaibin Niu, Kaidi Xing, Juanping Sun, Wenge Su, Yifei Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Pharmacology
Subjects:
amiodarone
oral
intravenous
FDA
adverse events
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1517616/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2025.1517616/full

Similar Items